Pleural and Peritoneal Mesothelioma Combination Can Be Managed

A patient diagnosed with pleural and peritoneal mesothelioma today can survive well beyond expectations, provided personalized treatment can be found at a specialty center.
Research from the Columbia University Medical Center in New York City has shown that despite the poor prognosis typically accompanies this rare diagnosis, patients still can thrive.
“This is an understudied, and poorly understood, group of patients that often is just written off,” surgical oncologist Dr. Michael Kluger at Columbia told The Mesothelioma Center at Asbestos.com. “But we’ve shown a meaningful survival.”
Kluger, who specializes in peritoneal mesothelioma, is co-author of a recent, single-center study.
The cohort included 50 patients spanning 21 years who were treated for malignant mesothelioma in the thoracic (pleural) and abdominal (peritoneal) cavities at the New York Presbyterian Hospital/Columbia Medical Center.
Annals of Surgical Oncology published the study in its January 2020 issue.

Find Top Cancer Centers Near You

State:

Please Select a State
AlabamaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIllinoisIndianaKansasLouisianaMaineMarylandMassachusettsMichiganMinnesotaMissouriMontanaNebraskaNevadaNew JerseyNew YorkNorth CarolinaOhioOregonPennsylvaniaSouth CarolinaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.Wiscons...

Source: Asbestos and Mesothelioma News - January 9, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news